{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:51:51Z","timestamp":1791395511137,"version":"4.3.3"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025A1515011006"],"award-info":[{"award-number":["2025A1515011006"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2024ZD0520303"],"award-info":[{"award-number":["2024ZD0520303"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014219","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005153","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","award":["82425045"],"award-info":[{"award-number":["82425045"]}],"id":[{"id":"10.13039\/501100005153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272800"],"award-info":[{"award-number":["82272800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.canlet.2026.218696","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:36:07Z","timestamp":1782491767000},"page":"218696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["VG161 oncolytic virus remodels the tumor microenvironment by expanding CD3+ macrophages and enhancing antitumor immunity"],"prefix":"10.1016","volume":"657","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8966-6451","authenticated-orcid":false,"given":"Fan","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6873-8026","authenticated-orcid":false,"given":"Yanhong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218696_bib1","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218696_bib2","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3748\/wjg.v29.i10.1569","article-title":"Systemic treatment for metastatic colorectal cancer","volume":"29","author":"Leowattana","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2026.218696_bib3","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy\u2014current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218696_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/gastro\/goz061","article-title":"Immunotherapy with immune checkpoint inhibitors in colorectal cancer: what is the future beyond deficient mismatch-repair tumours?","volume":"8","author":"Huyghe","year":"2020","journal-title":"Gastroenterol. Rep."},{"key":"10.1016\/j.canlet.2026.218696_bib5","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.7150\/thno.76854","article-title":"Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy","volume":"12","author":"Liu","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218696_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","article-title":"Turning cold tumors hot: from molecular mechanisms to clinical applications","volume":"43","author":"Zhang","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.canlet.2026.218696_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-981-10-7230-7_4","article-title":"Oncolytic virotherapy by HSV","volume":"1045","author":"Watanabe","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.canlet.2026.218696_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.trecan.2023.09.012","article-title":"Integrating innate and adaptive immunity in oncolytic virus therapy","volume":"10","author":"DePeaux","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2026.218696_bib9","article-title":"VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes","author":"Shen","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.canlet.2026.218696_bib10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3892\/ol.2024.14377","article-title":"Oncolytic virotherapy stimulates anti-tumor immune response and demonstrates activity in advanced sarcoma: report of two cases","volume":"27","author":"Qiu","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2026.218696_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28768","article-title":"Combination of novel oncolytic herpesvirus with paclitaxel as an efficient strategy for breast cancer therapy","volume":"95","author":"Deng","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.canlet.2026.218696_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-025-08717-5","article-title":"Oncolytic virus VG161 in refractory hepatocellular carcinoma","volume":"641","author":"Shen","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218696_bib13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ccell.2022.02.013","article-title":"Immune phenotypic linkage between colorectal cancer and liver metastasis","volume":"40","author":"Liu","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218696_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218696_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-02005-w","article-title":"Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218696_bib16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41423-025-01297-4","article-title":"Adjusting the scope of natural killer cells in cancer therapy","volume":"22","author":"Shen","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.canlet.2026.218696_bib17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","article-title":"Roles of macrophages in tumor development: a spatiotemporal perspective","volume":"20","author":"Bied","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.canlet.2026.218696_bib18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2026.218696_bib19","series-title":"Image-Guided Intratumoral Immunotherapy: Developing a Clinically Practical Technology","author":"Som","year":"2022"},{"key":"10.1016\/j.canlet.2026.218696_bib20","article-title":"JEV infection induces M-MDSC differentiation into CD3+ macrophages in the brain","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218696_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002375","article-title":"A TNF-regulated recombinatorial macrophage immune receptor implicated in granuloma formation in tuberculosis","volume":"7","author":"Beham","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.canlet.2026.218696_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/ijms23010329","article-title":"Mycobacterium tuberculosis H37Rv strain increases the frequency of CD3+TCR+ macrophages and affects their phenotype, but not their migration ability","volume":"23","author":"Ramon-Luing","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.canlet.2026.218696_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1030222","article-title":"Single-cell RNA sequencing reveals TCR+ macrophages in HPV-related head and neck squamous cell carcinoma","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218696_bib24","article-title":"The immune-metabolic crosstalk between CD3+C1q+TAM and CD8+ T cells associated with relapse-free survival in HCC","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218696_bib25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1600-6143.2007.02128.x","article-title":"The transcriptome of human cytotoxic T cells: similarities and disparities among allostimulated CD4+ CTL, CD8+ CTL and NK cells","volume":"8","author":"Hidalgo","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.canlet.2026.218696_bib26","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.7150\/thno.95971","article-title":"Single cell analyses reveal the PD-1 blockade response-related immune features in hepatocellular carcinoma","volume":"14","author":"Li","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218696_bib27","article-title":"Potential role of liver-resident CD3+ macrophages in HBV clearance in a mouse hepatitis B model","volume":"7","author":"Wang","year":"2025","journal-title":"JHEP Rep."},{"key":"10.1016\/j.canlet.2026.218696_bib28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2026.218696_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218696_bib30","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.it.2022.08.004","article-title":"Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.canlet.2026.218696_bib31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/antib13040094","article-title":"Enhancing tumor immunity with IL-12 and PD-1 blockade: a strategy for inducing robust central memory T cell responses in resistant cancer model","volume":"13","author":"Chen","year":"2024","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.canlet.2026.218696_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45948-w","article-title":"In vitro modelling of local gene therapy with IL-15\/IL-15R\u03b1 and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells","volume":"13","author":"Awad","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218696_bib33","article-title":"Next-generation anti-PD-L1\/IL-15 immunocytokine elicits superior antitumor immunity in cold tumors with minimal toxicity","volume":"5","author":"Shi","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.canlet.2026.218696_bib34","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.4110\/in.2024.24.e11","article-title":"IL-15 in T-Cell responses and immunopathogenesis","volume":"24","author":"Lee","year":"2024","journal-title":"Immune Netw."},{"key":"10.1016\/j.canlet.2026.218696_bib35","first-page":"1563","article-title":"Immunology of IL-12: an update on functional activities and implications for disease","volume":"19","author":"Ullrich","year":"2020","journal-title":"EXCLI J."},{"key":"10.1016\/j.canlet.2026.218696_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114824","article-title":"Mechanisms of CD8+ T cell exclusion and dysfunction in cancer resistance to anti-PD-(L)1","volume":"163","author":"Mortezaee","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2026.218696_bib37","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ni.3298","article-title":"The burgeoning family of unconventional T cells","volume":"16","author":"Godfrey","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2026.218696_bib38","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/eji.200737688","article-title":"Notch signaling is necessary for GATA3 function in the initiation of T cell development","volume":"38","author":"Hozumi","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2026.218696_bib39","doi-asserted-by":"crossref","first-page":"20060","DOI":"10.1073\/pnas.1110230108","article-title":"T-cell factor 1 is a gatekeeper for T-cell specification in response to notch signaling","volume":"108","author":"Germar","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218696_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","article-title":"Key chemokines direct migration of immune cells in solid tumors","volume":"29","author":"Kohli","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2026.218696_bib41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbmt.2009.12.002","article-title":"Chemokine receptor CCR5 mediates AlloImmune responses in graft-versus-host disease","volume":"16","author":"Palmer","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.canlet.2026.218696_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/126954","article-title":"CC chemokine receptor 5: the interface of host immunity and cancer","volume":"2014","author":"de Oliveira","year":"2014","journal-title":"Dis. Markers"},{"key":"10.1016\/j.canlet.2026.218696_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109438","article-title":"IL-15 enhances CCR5-mediated migration of memory CD8+ T cells by upregulating CCR5 expression in the absence of TCR stimulation","volume":"36","author":"Seo","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218696_bib44","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti\u2013PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218696_bib45","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1038\/s41598-020-62509-7","article-title":"A multi-batch design to deliver robust estimates of efficacy and reduce animal use \u2013 a syngeneic tumour case study","volume":"10","author":"Karp","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218696_bib46","article-title":"Do multiple experimenters improve the reproducibility of animal studies?","volume":"20","author":"Von Kortzfleisch","year":"2022","journal-title":"PLoS Biol."},{"key":"10.1016\/j.canlet.2026.218696_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002107","article-title":"Depth of tumor implantation affects response to in situ vaccination in a syngeneic murine melanoma model","volume":"9","author":"Carlson","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218696_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00384-024-04790-w","article-title":"Advancements in immunotherapy for colorectal cancer treatment: a comprehensive review of strategies, challenges, and future prospective","volume":"40","author":"Kaviyarasan","year":"2024","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.canlet.2026.218696_bib49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41571-024-00943-6","article-title":"Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response","volume":"21","author":"Williams","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218696_bib50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13045-022-01294-4","article-title":"Exploring immunotherapy in colorectal cancer","volume":"15","author":"Weng","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218696_bib51","article-title":"Immunotherapy in colorectal cancer: statuses and strategies","volume":"11","author":"Li","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.canlet.2026.218696_bib52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field of oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2026.218696_bib53","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/mt.2015.109","article-title":"Phase 1b trial of biweekly intravenous pexa-vec (JX-594), an oncolytic and immunotherapeutic Vaccinia virus in colorectal cancer","volume":"23","author":"Park","year":"2015","journal-title":"Mol. Ther."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352600460X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352600460X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:19:49Z","timestamp":1785889189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352600460X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":53,"alternative-id":["S030438352600460X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218696","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VG161 oncolytic virus remodels the tumor microenvironment by expanding CD3+ macrophages and enhancing antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218696"}}